Lipid Emulsion Therapy in Women with Recurrent Pregnancy Loss and Repeated Implantation Failure: The Role of Abnormal Natural Killer Cell Activity

Overview

Journal J Cell Mol Med

Specialties Cell Biology
Molecular Biology

Date 2021 Feb 5

PMID 33544456

Citations 7

Authors

Paula Renata Bueno Campos Canella

Ricardo Barini

Patricia de Oliveira Carvalho

Daniela Soares Razolli

Affiliations

Soon will be listed here.

Abstract

Altered immune and/or inflammatory response plays an important role in cases of recurrent pregnancy loss (RPL) and repeated implantation failure (RIF). Exacerbation of the maternal immune response through increased NK cell activity and inflammatory cytokines can cause embryo rejection leading to abortion or embryo implantation failure. Immunosuppressors or immunomodulators can help or prevent this condition. Currently, lipid emulsion therapy (LET) has emerged as a treatment for RPL and RIF in women with abnormal NK cell activity, by decreasing the exacerbated immune response of the maternal uterus and providing a more receptive environment for the embryo. However, the mechanisms by which the intralipid acts to reduce NK cell activity are still unclear. In this review, we focus on the studies that conducted LET to treat patients with RPL and RIF with abnormal NK cell activity. We find that although some authors recommend LET as an effective intervention, more studies are necessary to confirm its effectiveness in restoring NK cell activity to normal levels and to comprehend the underlying mechanisms of the lipids action in ameliorating the maternal environment and improving the pregnancy rate.

Citing Articles

Expression of NKp46 and other activating inhibitory receptors on uterine endometrial NK cells in females with various reproductive failures: A review.

Mai C, Fukui A, Saeki S, Takeyama R, Yamaya A, Shibahara H Reprod Med Biol. 2025; 24(1):e12610.

PMID: 39807425 PMC: 11725765. DOI: 10.1002/rmb2.12610.

The landscape of recurrent spontaneous abortion registered on clinical trials.gov.

Zhou X, Lai F, Chen W, Zhou C, Deng Y, Wang T Front Endocrinol (Lausanne). 2025; 15:1460968.

PMID: 39758339 PMC: 11695215. DOI: 10.3389/fendo.2024.1460968.

Endometrial scratching and intralipid treatment-no general recommendations.

Mrosk P, Sandi-Monroy N, Gagsteiger F, Friedl T, Hancke K, Bundschu K Front Reprod Health. 2024; 6:1505842.

PMID: 39665034 PMC: 11631846. DOI: 10.3389/frph.2024.1505842.

Immune Cell Functionality during Decidualization and Potential Clinical Application.

Stope M, Mustea A, Sanger N, Einenkel R Life (Basel). 2023; 13(5).

PMID: 37240742 PMC: 10223169. DOI: 10.3390/life13051097.

Blood serum lipid profiling may improve the management of recurrent miscarriage: a combination of machine learning of mid-infrared spectra and biochemical assays.

Guleken Z, Yalcin Bahat P, Toto O, Bulut H, Jakubczyk P, Cebulski J Anal Bioanal Chem. 2022; 414(29-30):8341-8352.

PMID: 36227296 DOI: 10.1007/s00216-022-04370-3.

References

Wong L, Porter T, Scott J . Immunotherapy for recurrent miscarriage. Cochrane Database Syst Rev. 2014; (10):CD000112. PMC: 7051032. DOI: 10.1002/14651858.CD000112.pub3. View

Canella P, Barini R, de Oliveira Carvalho P, Razolli D . Lipid emulsion therapy in women with recurrent pregnancy loss and repeated implantation failure: The role of abnormal natural killer cell activity. J Cell Mol Med. 2021; 25(5):2290-2296. PMC: 7933936. DOI: 10.1111/jcmm.16257. View

Karami N, Boroujerdnia M, Nikbakht R, Khodadadi A . Enhancement of peripheral blood CD56(dim) cell and NK cell cytotoxicity in women with recurrent spontaneous abortion or in vitro fertilization failure. J Reprod Immunol. 2012; 95(1-2):87-92. DOI: 10.1016/j.jri.2012.06.005. View

Kuon R, Weber M, Heger J, Santillan I, Vomstein K, Bar C . Uterine natural killer cells in patients with idiopathic recurrent miscarriage. Am J Reprod Immunol. 2017; 78(4). DOI: 10.1111/aji.12721. View

Achilli C, Duran-Retamal M, Saab W, Serhal P, Seshadri S . The role of immunotherapy in in vitro fertilization and recurrent pregnancy loss: a systematic review and meta-analysis. Fertil Steril. 2018; 110(6):1089-1100. DOI: 10.1016/j.fertnstert.2018.07.004. View

Udelsmann A, Dreyer E, Melo M, Bonfim M, Borsoi L, de Oliveira T . Lipids in local anesthetic toxicity. Arq Bras Cir Dig. 2013; 25(3):169-72. DOI: 10.1590/s0102-67202012000300007. View

Dakhly D, Bayoumi Y, Sharkawy M, Gad Allah S, Hassan M, Gouda H . Intralipid supplementation in women with recurrent spontaneous abortion and elevated levels of natural killer cells. Int J Gynaecol Obstet. 2016; 135(3):324-327. DOI: 10.1016/j.ijgo.2016.06.026. View

Mariee N, Li T, Laird S . Expression of leukaemia inhibitory factor and interleukin 15 in endometrium of women with recurrent implantation failure after IVF; correlation with the number of endometrial natural killer cells. Hum Reprod. 2012; 27(7):1946-54. DOI: 10.1093/humrep/des134. View

Roussev R, Donskoi B, Stamatkin C, Ramu S, Chernyshov V, Coulam C . Preimplantation factor inhibits circulating natural killer cell cytotoxicity and reduces CD69 expression: implications for recurrent pregnancy loss therapy. Reprod Biomed Online. 2012; 26(1):79-87. DOI: 10.1016/j.rbmo.2012.09.017. View

10.

Fukui A, Funamizu A, Fukuhara R, Shibahara H . Expression of natural cytotoxicity receptors and cytokine production on endometrial natural killer cells in women with recurrent pregnancy loss or implantation failure, and the expression of natural cytotoxicity receptors on peripheral blood natural.... J Obstet Gynaecol Res. 2017; 43(11):1678-1686. DOI: 10.1111/jog.13448. View

11.

Bae H, Lee G, Seong J, Gwak H . Outcomes with perioperative fat emulsions containing omega-3 fatty acid: A meta-analysis of randomized controlled trials. Am J Health Syst Pharm. 2017; 74(12):904-918. DOI: 10.2146/ajhp151015. View

12.

Simon A, Laufer N . Assessment and treatment of repeated implantation failure (RIF). J Assist Reprod Genet. 2012; 29(11):1227-39. PMC: 3510376. DOI: 10.1007/s10815-012-9861-4. View

13.

Shreeve N, Sadek K . Intralipid therapy for recurrent implantation failure: new hope or false dawn?. J Reprod Immunol. 2011; 93(1):38-40. DOI: 10.1016/j.jri.2011.11.003. View

14.

Martini A, Jasulaitis S, Fogg L, Uhler M, Hirshfeld-Cytron J . Evaluating the Utility of Intralipid Infusion to Improve Live Birth Rates in Patients with Recurrent Pregnancy Loss or Recurrent Implantation Failure. J Hum Reprod Sci. 2018; 11(3):261-268. PMC: 6262661. DOI: 10.4103/jhrs.JHRS_28_18. View

15.

Azargoon A, Mirrasouli Y, Shokrollahi Barough M, Barati M, Kokhaei P . The State of Peripheral Blood Natural Killer Cells and Cytotoxicity in Women with Recurrent Pregnancy Loss and Unexplained Infertility. Int J Fertil Steril. 2019; 13(1):12-17. PMC: 6334012. DOI: 10.22074/ijfs.2019.5503. View

16.

Harrity C, Bereir M, Walsh D, Marron K . Moving from peripheral blood to local uterine immunophenotype analysis in patients with poor reproductive history: pilot study of a novel technique. Ir J Med Sci. 2018; 188(3):893-901. DOI: 10.1007/s11845-018-1933-8. View

17.

Kuon R, Vomstein K, Weber M, Muller F, Seitz C, Wallwiener S . The "killer cell story" in recurrent miscarriage: Association between activated peripheral lymphocytes and uterine natural killer cells. J Reprod Immunol. 2016; 119:9-14. DOI: 10.1016/j.jri.2016.11.002. View

18.

Vivier E, Raulet D, Moretta A, Caligiuri M, Zitvogel L, Lanier L . Innate or adaptive immunity? The example of natural killer cells. Science. 2011; 331(6013):44-9. PMC: 3089969. DOI: 10.1126/science.1198687. View

19.

Zegers-Hochschild F, Adamson G, Dyer S, Racowsky C, de Mouzon J, Sokol R . The International Glossary on Infertility and Fertility Care, 2017. Fertil Steril. 2017; 108(3):393-406. DOI: 10.1016/j.fertnstert.2017.06.005. View

20.

Santillan I, Lozano I, Illan J, Verdu V, Coca S, Bajo-Arenas J . Where and when should natural killer cells be tested in women with repeated implantation failure?. J Reprod Immunol. 2015; 108:142-8. DOI: 10.1016/j.jri.2014.12.009. View